Active	Status	Sponsor type	Region	Phase	Filter
5 Active 7 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jimeno, Antonio
COMMANDER-001, NCT05357898: Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors	Terminated	1/2	20	US	SQZ-eAPC-HPV, Pembrolizumab	SQZ Biotechnologies	Adult Solid Tumor	11/23	11/23
NCT04440735: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors	Active, not recruiting	1/2	125	US	DSP107, Atezolizumab	Kahr Medical	Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer	09/25	09/25
NCT06384352: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors	Recruiting	1	155	Canada, US, RoW	YL211	MediLink Therapeutics (Suzhou) Co., Ltd., Hoffmann-La Roche	Advanced Solid Tumors	04/27	04/29
NCT05053737: Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC	Completed	1	11	US	Atezolizumab, MPDL3280A, RG7446, Tecentriq, Stereotactic Body Radiation Therapy, SBRT	University of Colorado, Denver, Genentech, Inc.	Squamous Cell Carcinoma of Head and Neck	11/23	06/24